TACSTD2 and cancer: Trophoblast cell surface antigen-2 (TROP2), a type I cell surface glycoprotein, has been recognized as a pan-cancer target which is overexpressed in most solid tumors, and its overexpression has been linked to poor prognosis and increased risk of metastasis [12–14].